Dietmar Berger
Chief Medical Officer
Other
Other
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Gilead Sciences, Inc. (GILD) | M.D., Ph.D. Chief Medical Officer | $969,231 | $13,922,878 |
| 2018 | Atara Biotherapeutics, Inc. (ATRA) | M.D., Ph.D. Former Global Head of Research & Development | $320,385 | $4,972,439 |
Earnings-call appearances
-
Gilead Sciences Q2 2026 Earnings Conference Call2026-08-04
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q1 FY2026 Earnings Call2026-05-07
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q4 FY2025 Earnings Call2026-02-10
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q3 FY2025 Earnings Call2025-10-30
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q2 FY2025 Earnings Call2025-08-07
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q1 FY2025 Earnings Call2025-04-24
Gilead Sciences, Inc. (GILD)
-
Gilead Sciences, Inc. Q4 FY2024 Earnings Call2025-02-11
Gilead Sciences, Inc. (GILD)